Traphaco JSC 2020 AR2
The report highlights Traphaco's performance in 2020, achieving a 12% increase in consolidated revenue to VND 1,909 billion and a 27% increase in consolidated profit after tax to VND 216.7 billion despite the COVID-19 pandemic. The company successfully launched new products like Boganic herbal tea and became the first Vietnamese pharmaceutical enterprise to register Ginkgo biloba under GACP-WHO standards. Traphaco also focused on building its new corporate culture and was recognized as one of Vietnam's Sustainable Enterprises (CSI 2020) for its commitment to a green value chain.
Company: Traphaco JSC
Sector: Health Care
Country: Vietnam
Year: 2020
Type: AR2
Pages: 109
Traphaco JSC
Annual Report
The report highlights Traphaco's performance in 2020, achieving a 12% increase in consolidated revenue to VND 1,909 billion and a 27% increase in consolidated profit after tax to VND 216.7 billion despite the COVID-19 pandemic. The company successfully launched new products like Boganic herbal tea and became the first Vietnamese pharmaceutical enterprise to register Ginkgo biloba under GACP-WHO standards. Traphaco also focused on building its new corporate culture and was recognized as one of Vietnam's Sustainable Enterprises (CSI 2020) for its commitment to a green value chain.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Published
Mar 5, 2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Water Consumption
Employees